Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 1,497,775 | 1,326,730 | 1,043,241 | 1,832,684 | 1,702,023 |
Marketable Securities | 237,025 | 262,756 | 259,351 | 284,870 | 284,195 |
Receivables | 356,182 | 420,250 | 351,522 | 308,809 | 276,116 |
Inventories | 17,012 | 16,335 | 13,977 | 11,400 | 7,365 |
TOTAL | $2,159,425 | $2,077,625 | $1,716,169 | $2,481,488 | $2,319,595 |
Non-Current Assets | |||||
PPE Net | 498,335 | 453,777 | 410,034 | 377,567 | 347,250 |
Investments And Advances | 225,473 | 248,731 | 180,993 | 133,657 | 117,902 |
Intangibles | 333,268 | 183,060 | 344,037 | 193,828 | 199,212 |
Other Non-Current Assets | 90,929 | 249,128 | 101,189 | 240,210 | 230,859 |
TOTAL | $1,148,005 | $1,134,696 | $1,036,253 | $945,262 | $895,223 |
Total Assets | $3,307,430 | $3,212,321 | $2,752,422 | $3,426,750 | $3,214,818 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 11,900 | 18,588 | 18,524 | 18,300 | N/A |
Accounts payable and accrued liabilities | 122,568 | 90,938 | 61,026 | 83,647 | 95,465 |
Accrued Expenses | 469,756 | 445,798 | 422,952 | 410,729 | 365,455 |
TOTAL | $606,202 | $556,513 | $503,412 | $513,340 | $461,683 |
Non-Current Liabilities | |||||
Other Non-Current Liabilities | 277,547 | 279,287 | 279,330 | 283,086 | 298,876 |
TOTAL | $310,395 | $311,204 | $311,289 | $315,004 | $330,608 |
Total Liabilities | $916,597 | $867,717 | $814,701 | $828,344 | $792,291 |
Shareholders' Equity | |||||
Shares Outstanding, K | 218,996 | 218,699 | 217,374 | 216,776 | 215,397 |
Common Shares | 219 | 218 | 217 | 216 | 215 |
Retained earnings | -1,876,305 | -1,861,102 | -2,151,400 | -1,430,758 | -1,541,763 |
Other shareholders' equity | -9,748 | -12,423 | -13,107 | -15,542 | -8,614 |
TOTAL | $2,390,833 | $2,344,604 | $1,937,721 | $2,598,406 | $2,422,527 |
Total Liabilities And Equity | $3,307,430 | $3,212,321 | $2,752,422 | $3,426,750 | $3,214,818 |